跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 123 条关于
“depemokimab-ulaa”
全部
123
临床试验
92
药物
11
机构
0
资讯
20
9个月前
FDA Approves GSK's Exdensur as First Ultra-Long-Acting Biologic for Severe Asthma
去年
GSK's Depemokimab Shows Promise in Severe Asthma Treatment
去年
EMA Accepts GSK's Depemokimab for Review in Asthma and CRSwNP
去年
GSK's Depemokimab Shows Positive Phase III Results in Chronic Rhinosinusitis with Nasal Polyps
2年前
GSK's Depemokimab Shows Promise in Reducing Severe Asthma Exacerbations
2年前
GSK's Depemokimab Shows Promise in Severe Asthma with Six-Month Dosing
10个月前
Q4 2025 Biotech Catalyst Monitor Identifies 20 Key Pipeline Events Including Cytokinetics' Aficamten and GSK's Depemokimab
去年
Pulmonology Updates: Dupixent for COPD, Benralizumab for EGPA, and Depemokimab for Severe Asthma
去年
GSK to Present Groundbreaking Respiratory Medicine Data at ATS 2025 International Congress
去年
Tezspire Shows Promise in Phase III Trial for Chronic Rhinosinusitis with Nasal Polyps
第 1 页,共 2 页
上一页
下一页